
Our medical experts are ready to answer your questions and guide you through your treatment options.
Understanding the Preimplantation Genetic Testing (PGT) success rate is crucial for individuals considering this advanced fertility treatment. Success is influenced by various factors, including the specific PGT type, underlying conditions, and individual patient profiles. Pune has emerged as a significant center for fertility treatments, with its outcomes being carefully reviewed.
In Pune, PGT success rates are evaluated through aggregated clinical data from various fertility clinics. This allows for a comprehensive assessment of outcomes. It is important to remember that individual results will vary based on specific treatment protocols, the developmental stage of embryos affecting their survival, and unique patient characteristics.
For Preimplantation Genetic Testing (PGT), "success" encompasses multiple critical outcomes. Primarily, it means accurately identifying chromosomal abnormalities or specific genetic disorders in embryos. Further success indicators include the embryo's viability post-biopsy, successful implantation after transfer, achieving a clinical pregnancy, and ultimately, a live birth, representing the successful recovery of reproductive aspirations.
Success rates vary depending on treatment approach and patient factors.
| Treatment Type / Category | Typical Use Case | Success Rate Range (%) | What Success Indicates |
|---|---|---|---|
| PGT-A (Aneuploidy Screening) | Identifying chromosomal abnormalities in embryos | 50%–75% per euploid embryo transfer | Reduced miscarriage risk, improved implantation and live birth rates |
| PGT-M (Monogenic Disorder) | Detecting specific single-gene disorders | 95%–99% diagnostic accuracy | Transfer of unaffected embryos, preventing genetic disease inheritance |
| PGT-SR (Structural Rearrangement) | For chromosomal structural rearrangements | 45%–65% clinical pregnancy per normal/balanced embryo transfer | Lower risk of miscarriage and birth defects |
The Preimplantation Genetic Testing (PGT) survival rate by age in Pune closely mirrors international trends, where maternal age is a primary determinant of euploid embryo yield and subsequent live birth rates. Globally, younger patients generally have more chromosomally normal embryos available for transfer, impacting overall success.
| Maternal Age Group | PGT Outcome (Euploid Embryos) | Live Birth Rate Range (%) after PGT-A |
|---|---|---|
| Under 35 years | Higher yield of euploid embryos | 55%–70% |
| 35-37 years | Moderate yield of euploid embryos | 45%–60% |
| 38-40 years | Lower yield of euploid embryos | 35%–50% |
| Over 40 years | Significantly lower yield of euploid embryos | 20%–35% |
Success rates for Preimplantation Genetic Testing (PGT) in India are comparable with international standards when similar protocols, technology, and patient selection are applied.
| Country | PGT Live Birth Rate Range (%) (per euploid embryo transfer) |
|---|---|
| India | 50%–65% |
| United States | 55%–70% |
| United Kingdom | 50%–65% |
| Australia | 55%–70% |
| Spain | 50%–65% |
| Canada | 50%–65% |
These rates are indicative and can vary significantly based on individual patient health, specific clinical protocols, and diverse population characteristics in different regions.
Understanding Preimplantation Genetic Testing (PGT) outcomes empowers individuals to make informed choices. Focus on comprehensive discussions with specialists to tailor your treatment plan based on personal circumstances and the latest evidence.
India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.
Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.
Get Personalized Medical Treatment Options From India's Top Hospitals. Our Medical Experts Are Ready To Assist You Every Step Of The Way.